In addition, ofatumumab is able to lyse cell lines expressing low levels of CD20, which are not efficiently killed by rituximab [21]
In addition, ofatumumab is able to lyse cell lines expressing low levels of CD20, which are not efficiently killed by rituximab [21]. clinicians for over a...